Do you have the same question? Follow this Question
Aug 16, 2024 - 11:58 AM
We’ve provided several answers to questions related to Tradjenta (Linagliptin) , see some other helpful Q&A related to this product.
Question: What precautions should I take while using this product?
Answer: Monitor symptoms of low blood sugar, such as sweating, nervousness, shakiness, hunger, confusion, irritability, and/or rapid heartbeat. Being aware of these precautions helps in managing potential side effects and ensuring effective treatment.
Question: Can this product be taken during pregnancy?
Answer: This product is not recommended for use during pregnancy. Pregnant women need to consult their healthcare provider for safer alternatives to manage their condition.
Question: What is the active ingredient in this product?
Answer: The active ingredient in this product is Linagliptin, a DPP-4 inhibitor. Knowing the active ingredient helps in understanding how the drug works to lower blood sugar levels in type 2 diabetes.
Question: What is the DrugBank ID for this product?
Answer: The DrugBank ID for this product is DB08882. DrugBank is a comprehensive database that provides detailed drug information, including chemical, pharmacological, and pharmaceutical data.
Question: What is the PubChem CID for this product?
Answer: The PubChem CID for this product is 10096344. This unique identifier helps researchers and healthcare providers find detailed chemical information about the drug.
Question: What is the strength of this product?
Answer: The strength of this product is 5 mg. Knowing the dosage strength helps ensure that patients take the correct amount to manage their condition effectively.
Question: What is the elimination half-life of this product?
Answer: The elimination half-life of this product is around 24 hours. This indicates how long it takes for half of the drug to be eliminated from the body, affecting how frequently the medication needs to be taken.
